Literature DB >> 28765828

Data on gender contrasts in the risk of incident myocardial infarction by age. The Tromsø Study 1979-2012.

Grethe Albrektsen1, Ivar Heuch2, Maja-Lisa Løchen3, Dag Steinar Thelle4,5, Tom Wilsgaard3, Inger Njølstad3, Kaare Harald Bønaa1,3,6.   

Abstract

The data presented in this article relate to the research article entitled "Risk of incident myocardial infarction by gender: Interactions with serum lipids, blood pressure and smoking. The Tromsø Study 1979-2012" (Albrektsen et al., 2017) [1]. Data quantify the gender differences in the risk of myocardial infarction (MI) in terms of incidence rate ratios (IRR), in subgroups defined by serum lipids, blood pressure and smoking among persons aged 35-54 years, 55-74 years and 75-94 years, respectively. Data also describe the age- and gender-specific linear associations with the coronary heart disease (CHD) risk factors. IRRs for combined categories of age, gender and a CHD risk factor, with each category compared to the same reference group, are also shown. IRRs were calculated as estimates of relative risk in Poisson regression analyses of person-years at risk. Among 33,859 individuals at risk, a total of 622, 1308 and 816 were diagnosed with MI at ages 35-54, 55-74 and 75-94 years, respectively.

Entities:  

Keywords:  Age; Blood pressure; Gender; Lipids; Myocardial infarction; Relative risk; Smoking

Year:  2017        PMID: 28765828      PMCID: PMC5527133          DOI: 10.1016/j.dib.2017.07.001

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications Table Value of the data Data can be used for identifying subgroups where the gender contrast in risk of incident MI is particularly high or low. Data can be used for evaluation of gender heterogeneity in the association with established CHD risk factors. Data can be used for comparing risk of incident MI between any subgroups defined by age, gender and a CHD risk factor. Data can be utilized for exploring issues that can improve knowledge on biological mechanisms underlying the gender contrast in the risk of CHD. At the community level, data can be utilized for development of gender-specific CHD risk preventive guidelines.

Data

Data displayed in Table 1 are age- and gender-specific incidence rate ratios (IRR) of myocardial infarction (MI) with 95% confidence intervals (CI) for the linear associations with total cholesterol, high-density lipoprotein cholesterol (HDL-C), and HDL-C in percent of total cholesterol. Data shown in Table 2 are the age-specific IRR for gender (men vs. women) within categories defined by the lipid components. Table 3, Table 4 show corresponding numbers for the interaction between gender and systolic and diastolic blood pressure, and Table 5 shows IRR for the interaction between gender and daily smoking. The number of MI-diagnoses within each subgroup defined by age, gender and a CHD risk factor, is also shown. Fig. 1A-F show IRR values from analyses of combined categories of age (35–54, 55–74 and 75–94 years), gender and each CHD risk factor, with each subgroup compared to the same reference group. The data are original and have not been published elsewhere.
Table 1

Age- and gender-specific incidence rate ratio of myocardial infarction for linear association with serum lipids. The Tromsø Study 1979–2012.

35–54 years55–74 years75–94 years
IRR (95% CI)aIRR (95% CI)aIRR (95% CI)ap, interactionb
TC (per 1.50 mmol/L)c,d
– Men2.02 (1.82–2.23)1.54 (1.43–1.67)1.21 (1.07–1.38)<0.001
– Women2.10 (1.64–2.70)1.38 (1.21–1.56)1.06 (0.95–1.20)<0.001
p, interactione0.750.120.13
HDL-C (per 0.30 mmol/L)c,d
– Men0.72 (0.66–0.79)0.76 (0.72–0.81)0.91 (0.84–0.99)<0.001
– Women0.76 (0.63–0.92)0.73 (0.67–0.80)0.82 (0.76–0.88)0.27
p, interactione0.620.440.062
HDL-C/TC (per 5%)
– Men0.60 (0.55–0.64)0.68 (0.64–0.72)0.89 (0.82–0.96)<0.001
– Women0.57 (0.48–0.68)0.71 (0.65–0.78)0.81 (0.75–0.88)<0.001
p, interactione0.660.420.12

IRR, incidence rate ratio; CI, confidence interval; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol.

IRR for linear trend through ordered lipid categories (see Table 2), adjusted for age (1-year interval, categorical), birth-cohort (5-year categories), diastolic blood pressure (linear trend) and daily smoking.

Likelihood ratio test for linear interaction (age*lipid component) for men and women.

Additional adjustment for HDL-C or total cholesterol.

To convert mmol/L to mg/dL, divide by 0.0259 (or multiply with 38.61004).

Likelihood ratio test for linear interaction (gender*lipid component) within age groups.

Table 2

Age-specific incidence rate ratio of myocardial infarction for gender within serum lipid categories. The Tromsø Study 1979–2012.

35–54 years
55–74 years
75–94 years
No. of MI
IRR (95% CI)aNo. of MI
IRR (95% CI)aNo. of MI
IRR (95% CI)a
MWMen vs. womenMWMen vs. womenMWMen vs. women
TC (mmol/L)b,c
<5.03474.73 (2.09–10.7)60171.87 (1.09–3.21)57311.13 (0.72–1.76)
5.0–6.4165274.21 (2.79–6.36)3351071.85 (1.48–2.31)1721161.55 (1.21–1.98)
6.5–7.9223353.22 (2.24–4.62)4181522.27 (1.87–2.75)1241841.68 (1.31–2.14)
≥8.0120114.61 (2.54–8.39)146732.28 (1.71–3.03)38942.23 (1.52–3.29)
p, interactiond0.620.490.15
HDL-C (mmol/L)b,c
<1.001073e150261.96 (1.29–2.98)48281.44 (0.90–2.30)
1.0–1.29243214.37 (2.91–6.57)351811.98 (1.55–2.53)1321041.35 (1.03–1.77)
1.3–1.59126263.58 (2.34–5.46)2821072.21 (1.77–2.77)1161151.72 (1.31–2.25)
1.6–1.8948183.92 (2.28–6.75)114762.09 (1.56–2.80)52881.60 (1.12–2.28)
≥1.9018123.33 (1.60–6.92)62592.30 (1.61–3.30)43902.16 (1.48–3.14)
p, interactiond0.890.940.33
HDL-C/TC (%)
<1516194.15 (2.12–8.13)195382.48 (1.75–3.52)48481.57 (1.04–2.36)
15–19.9211262.91 (1.94–4.38)3651081.89 (1.52–2.35)1011221.25 (0.95–1.65)
20–24.994183.49 (2.10–5.78)217941.92 (1.50–2.45)1211241.89 (1.45–2.45)
25–29.945134.03 (2.17–7.47)114552.13 (1.54–2.94)65651.96 (1.38–2.79)
≥3031144.84 (2.57–9.12)68541.86 (1.30–2.66)56661.74 (1.21–2.51)
p, interactiond0.700.690.17

MI, myocardial infarction; IRR, incidence rate ratio; CI, confidence interval; M, men; W, women; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol.

Adjusted for age (1-year interval, categorical), birth-cohort (5-year categories), diastolic blood pressure (linear trend) and daily smoking.

Additional adjustment for HDL-C or total cholesterol.

To convert mmol/L to mg/dL, divide by 0.0259 (or multiply with 38.61004).

Likelihood ratio test for categorical interaction (gender*lipid component) within age groups.

Two first categories collapsed.

Table 3

Age- and gender-specific incidence rate ratio of myocardial infarction for linear association with blood pressure. The Tromsø study 1979–2012.

35–54 years55–74 years75–94 years
IRR (95% CI)aIRR (95% CI)aIRR (95% CI)ap, interactionb
SBP (per 20 mmHg)
– Men1.53 (1.38–1.70)1.21 (1.14–1.29)1.16 (1.06–1.27)0.002
– Women1.70 (1.36–2.13)1.41 (1.29–1.55)1.29 (1.18–1.41)0.39
p, interactionc0.400.0070.10
DBP (per 10 mmHg)
– Men1.45 (1.33–1.58)1.20 (1.13–1.28)1.07 (0.97–1.18)<0.001
– Women1.74 (1.42–2.13)1.34 (1.22–1.48)1.24 (1.13–1.37)0.039
p, interactionc0.0950.0450.038

IRR, incidence rate ratio; CI, confidence interval; SBP, systolic blood pressure; DBP, diastolic blood pressure.

IRR for linear trend through ordered blood pressure categories (see Table 4), adjusted for age (1-year interval, categorical), birth-cohort (5-year categories), HDL-C in percent of total cholesterol (linear trend), and daily smoking.

Likelihood ratio test for linear interaction (age*BP) for men and women.

Likelihood ratio test for linear interaction (gender*BP) within age groups.

Table 4

Age-specific incidence rate ratio of myocardial infarction for gender within blood pressure categories. The Tromsø Study 1979–2012.

35–54 years
55–74 years
75–94 years
No. of MI
IRR (95% CI)aNo. of MI
IRR (95% CI)aNo. of MI
IRR (95% CI)a
MWMen vs. womenMWMen vs. womenMWMen vs. women
SBP (mmHg)
<12054184.67 (2.73–8.01)75303.20 (2.09–4.89)1682.52 (1.08–5.90)
120–139250393.02 (2.15–4.26)345882.53 (2.00–3.20)77531.91 (1.34–2.72)
140–159188144.45 (2.58–7.68)3361191.95 (1.58–2.42)1321141.75 (1.35–2.27)
160–1794152.31 (1.13–4.71)153771.73 (1.31–2.28)1081201.91 (1.46–2.51)
≥18094b50351.70 (1.10–2.62)581301.30 (0.94–1.79)
p, interactionc0.280.0470.28
DBP (mmHg)
<7041105.33 (2.66–10.7)50372.75 (1.80–4.21)48442.34 (1.55–3.54)
70–79130194.69 (2.89–7.62)212842.30 (1.78–2.96)94931.63 (1.21–2.18)
80–89196283.21 (2.15–4.78)3421211.95 (1.58–2.40)1501571.69 (1.33–2.14)
90–99109172.58 (1.54–4.31)237781.62 (1.25–2.10)901261.36 (1.04–1.80)
≥1006663.03 (1.31–7.01)118291.91 (1.27–2.87)95b
p, interactionc0.340.200.18

MI, myocardial infarction; IRR, incidence rate ratio; CI, confidence interval; M, men; W, women; SBP, systolic blood pressure; DBP, diastolic blood pressure.

Adjusted for age (1-year interval, categorical), birth-cohort (5-year categories), HDL-C in percent of total cholesterol (linear trend), and daily smoking.

Two last categories collapsed.

Likelihood ratio test for categorical interaction (gender*BP) within age groups.

Table 5

Age-specific incidence rate ratio of myocardial infarction for gender in smokers and non-smokers, and age- and gender-specific associations with smoking. The Tromsø Study 1979–2012.

35–54 years
55–74 years
75–94 years
No. of MI
IRR (95% CI)aNo. of MI
IRR (95% CI)aNo. of MI
IRR (95% CI)a
MWMen vs. womenMWMen vs. womenMWMen vs. women
Smoking, daily
 No6084.57 (2.17–9.60)143882.51 (1.92–3.28)622371.95 (1.47–2.58)
 Former (F)10885.27 (2.56–10.9)302652.21 (1.67–2.90)2401001.75 (1.38–2.21)
 Yes374643.25 (2.48–4.27)5141961.76 (1.48–2.08)89881.23 (0.91–1.65)
IRR, F vs. No
– Men1.80 (1.31–2.48)1.04 (0.85–1.27)1.12 (0.81–1.55)
– Women1.56 (0.59–4.16)1.18 (0.86–1.63)1.20 (0.95–1.52)
IRR, Yes vs. No
– Men3.68 (2.79–4.85)1.91 (1.59–2.31)1.08 (0.82–1.43)
– Women5.17 (2.47–10.8)2.74 (2.13–3.52)1.78 (1.39–2.28)
p, interactionb0.340.0570.067

MI, myocardial infarction; IRR, incidence rate ratio; CI, confidence interval; M, men; W, women.

Adjusted for age (1-year interval, categorical), birth-cohort (5-year categories), HDL-C in percent of total cholesterol (linear trend) and diastolic blood pressure (linear trend).

Likelihood ratio test for categorical interaction (gender*smoking) within age groups.

Fig. 1

Relative risk in combined categories of interacting factors. Adjusted incidence rate ratio (IRR, on logarithmic scale) of myocardial infarction in combined categories of age (— . — 35-54 yr, _____ 55-74 yr, - - - - 75-94 yr), gender ( men, women) and (A) total cholesterol, (B) HDL-C, (C) HDL-C in percent of total cholesterol, (D) systolic BP, (E) diastolic BP, (F) daily smoking. The horizontal reference line (IRR = 1.00) in each figure goes through the common reference group.

Relative risk in combined categories of interacting factors. Adjusted incidence rate ratio (IRR, on logarithmic scale) of myocardial infarction in combined categories of age (— . — 35-54 yr, _____ 55-74 yr, - - - - 75-94 yr), gender ( men, women) and (A) total cholesterol, (B) HDL-C, (C) HDL-C in percent of total cholesterol, (D) systolic BP, (E) diastolic BP, (F) daily smoking. The horizontal reference line (IRR = 1.00) in each figure goes through the common reference group. Age- and gender-specific incidence rate ratio of myocardial infarction for linear association with serum lipids. The Tromsø Study 1979–2012. IRR, incidence rate ratio; CI, confidence interval; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol. IRR for linear trend through ordered lipid categories (see Table 2), adjusted for age (1-year interval, categorical), birth-cohort (5-year categories), diastolic blood pressure (linear trend) and daily smoking. Likelihood ratio test for linear interaction (age*lipid component) for men and women. Additional adjustment for HDL-C or total cholesterol. To convert mmol/L to mg/dL, divide by 0.0259 (or multiply with 38.61004). Likelihood ratio test for linear interaction (gender*lipid component) within age groups. Age-specific incidence rate ratio of myocardial infarction for gender within serum lipid categories. The Tromsø Study 1979–2012. MI, myocardial infarction; IRR, incidence rate ratio; CI, confidence interval; M, men; W, women; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol. Adjusted for age (1-year interval, categorical), birth-cohort (5-year categories), diastolic blood pressure (linear trend) and daily smoking. Additional adjustment for HDL-C or total cholesterol. To convert mmol/L to mg/dL, divide by 0.0259 (or multiply with 38.61004). Likelihood ratio test for categorical interaction (gender*lipid component) within age groups. Two first categories collapsed. Age- and gender-specific incidence rate ratio of myocardial infarction for linear association with blood pressure. The Tromsø study 1979–2012. IRR, incidence rate ratio; CI, confidence interval; SBP, systolic blood pressure; DBP, diastolic blood pressure. IRR for linear trend through ordered blood pressure categories (see Table 4), adjusted for age (1-year interval, categorical), birth-cohort (5-year categories), HDL-C in percent of total cholesterol (linear trend), and daily smoking. Likelihood ratio test for linear interaction (age*BP) for men and women. Likelihood ratio test for linear interaction (gender*BP) within age groups. Age-specific incidence rate ratio of myocardial infarction for gender within blood pressure categories. The Tromsø Study 1979–2012. MI, myocardial infarction; IRR, incidence rate ratio; CI, confidence interval; M, men; W, women; SBP, systolic blood pressure; DBP, diastolic blood pressure. Adjusted for age (1-year interval, categorical), birth-cohort (5-year categories), HDL-C in percent of total cholesterol (linear trend), and daily smoking. Two last categories collapsed. Likelihood ratio test for categorical interaction (gender*BP) within age groups. Age-specific incidence rate ratio of myocardial infarction for gender in smokers and non-smokers, and age- and gender-specific associations with smoking. The Tromsø Study 1979–2012. MI, myocardial infarction; IRR, incidence rate ratio; CI, confidence interval; M, men; W, women. Adjusted for age (1-year interval, categorical), birth-cohort (5-year categories), HDL-C in percent of total cholesterol (linear trend) and diastolic blood pressure (linear trend). Likelihood ratio test for categorical interaction (gender*smoking) within age groups.

Experimental design, materials and methods

Population at risk

Data displayed are calculated on the basis of information from the Tromsø Study in Norway [1], [2]. Individual risk factor levels were obtained through questionnaires, blood samples and physical examinations in five repeated surveys in the calendar period 1979–2008. CHD risk factor levels in men and women at start of follow-up are given elsewhere [3]. Dates of MI-diagnoses, emigration and deaths in the period 1979–2012 were obtained from local and national registers. Among 33,859 individuals at risk (51% women), a total of 622 (80 women), 1308 (349 women) and 816 (425 women) had an MI at ages 35–54, 55–74 and 75–94 years, respectively.

Statistical analysis

The data are obtained from Poisson regression analyses of person-years at risk, with IRR of incident MI calculated as estimates of relative risk [4], [5]. Information from all repeated surveys was utilized [1]. The data shown in Table 1, Table 2, Table 3, Table 4, Table 5 are calculated on the basis of two-way interaction models (between gender and a CHD risk factor) in separate analyses of persons aged 35–54, 55–74 and 75–94 years (corresponding to a three-way interaction model). Within each broad age group, IRRs were adjusted for age in 1-year categories. The data displayed in Table 1, Table 2, Table 3, Table 4, Table 5 quantify subgroup-specific associations with each single risk factor, but provide no information on whether a high-risk group among young people encloses, or possibly crosses the risk level of any older subgroup. Data displayed in Fig. 1A–F are obtained from analyses of a single variable representing combined categories of age (35–54, 55–74 and 75–94 years), gender and a CHD risk factor (a unique value assigned to each possible value combination). A subgroup in middle-aged women with sufficient number of MI cases, as close as possible to normal-range or unexposed for the CHD risk factor considered, was used as common reference group when calculating the IRRs, and the risk estimates for all subgroups can be compared directly. The internal order of the IRRs will also reflect the rank of absolute risks. To ensure that persons in one particular broad age group were compared with persons exactly 20 years older or younger, additional indicator variables for age were included in the model (1-year categories, original age variable recoded 1–20 within each broad age group). The data presented in Fig. 1A–F provide information on whether a high-risk group in young people encloses the risk level of any older subgroup, but do not quantify the association with each single risk factor. The regression models used for generating the data are an extension of the two-way interaction models applied in the original research paper [1], to three-way-interaction models used for evaluation of homogeneity across age-groups.
Subject areaMedicine
More specific subject areaCoronary heart disease epidemiology
Type of dataTables and Figures
How data was acquiredPoisson regression analyses of person-years at risk, with calculations based on information obtained from a large population-based prospective study
Data formatAnalyzed
Experimental factors
Experimental features
Data source locationTromsø, Norway
Data accessibilityThe data are available with this article
  3 in total

1.  Risk of incident myocardial infarction by gender: Interactions with serum lipids, blood pressure and smoking. The Tromsø Study 1979-2012.

Authors:  Grethe Albrektsen; Ivar Heuch; Maja-Lisa Løchen; Dag Steinar Thelle; Tom Wilsgaard; Inger Njølstad; Kaare Harald Bønaa
Journal:  Atherosclerosis       Date:  2017-04-09       Impact factor: 5.162

2.  Lifelong Gender Gap in Risk of Incident Myocardial Infarction: The Tromsø Study.

Authors:  Grethe Albrektsen; Ivar Heuch; Maja-Lisa Løchen; Dag Steinar Thelle; Tom Wilsgaard; Inger Njølstad; Kaare Harald Bønaa
Journal:  JAMA Intern Med       Date:  2016-11-01       Impact factor: 21.873

3.  Cohort profile: the Tromso Study.

Authors:  Bjarne K Jacobsen; Anne Elise Eggen; Ellisiv B Mathiesen; Tom Wilsgaard; Inger Njølstad
Journal:  Int J Epidemiol       Date:  2011-03-21       Impact factor: 7.196

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.